Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Llinàs

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|March 18, 2008
Polymorph control: past, present and futureAntonio Llinàs, Jonathan M Goodman
Journal of Medicinal Chemistry|March 27, 2012
Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compoundsYidong Yang, Ola Engkvist, Antonio Llinàs, et al.
Journal of Chemical Information and Modeling|July 16, 2008
Solubility challenge: can you predict solubilities of 32 molecules using a database of 100 reliable measurements?Antonio Llinàs, Robert C Glen, Jonathan M Goodman
Journal of Medicinal Chemistry|December 22, 2011
Oxadiazoles in medicinal chemistryJonas Boström, Anders Hogner, Antonio Llinàs, et al.
Journal of Medicinal Chemistry|February 15, 2007
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal formsAntonio Llinàs, Jonathan C Burley, Karl J Box, et al.
Current Drug Metabolism|July 16, 2010
Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred modelHong Wan, Peter Bold, Lars-Olof Larsson, et al.
Molecular Pharmaceutics|February 23, 2008
Predicting intrinsic aqueous solubility by a thermodynamic cycleDavid S Palmer, Antonio Llinàs, Iñaki Morao, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitorsFabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|March 18, 2008
Polymorph control: past, present and futureAntonio Llinàs, Jonathan M Goodman
Journal of Medicinal Chemistry|March 27, 2012
Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compoundsYidong Yang, Ola Engkvist, Antonio Llinàs, et al.
Journal of Chemical Information and Modeling|July 16, 2008
Solubility challenge: can you predict solubilities of 32 molecules using a database of 100 reliable measurements?Antonio Llinàs, Robert C Glen, Jonathan M Goodman
Journal of Medicinal Chemistry|December 22, 2011
Oxadiazoles in medicinal chemistryJonas Boström, Anders Hogner, Antonio Llinàs, et al.
Journal of Medicinal Chemistry|February 15, 2007
Diclofenac solubility: independent determination of the intrinsic solubility of three crystal formsAntonio Llinàs, Jonathan C Burley, Karl J Box, et al.
Current Drug Metabolism|July 16, 2010
Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred modelHong Wan, Peter Bold, Lars-Olof Larsson, et al.
Molecular Pharmaceutics|February 23, 2008
Predicting intrinsic aqueous solubility by a thermodynamic cycleDavid S Palmer, Antonio Llinàs, Iñaki Morao, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitorsFabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, et al.
Pageof 1